Journey Medical (DERM) Non-Current Debt: 2020-2025
Historic Non-Current Debt for Journey Medical (DERM) over the last 3 years, with Sep 2025 value amounting to $19.5 million.
- Journey Medical's Non-Current Debt fell 1.27% to $19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year decrease of 1.27%. This contributed to the annual value of $24.9 million for FY2024, which is 70.15% up from last year.
- Per Journey Medical's latest filing, its Non-Current Debt stood at $19.5 million for Q3 2025, which was down 8.56% from $21.4 million recorded in Q2 2025.
- Journey Medical's 5-year Non-Current Debt high stood at $24.9 million for Q4 2024, and its period low was $9.9 million during Q1 2023.
- In the last 3 years, Journey Medical's Non-Current Debt had a median value of $19.7 million in 2024 and averaged $18.6 million.
- In the last 5 years, Journey Medical's Non-Current Debt tumbled by 32.81% in 2023 and then skyrocketed by 70.15% in 2024.
- Over the past 5 years, Journey Medical's Non-Current Debt (Quarterly) stood at $15.0 million in 2021, then spiked by 32.31% to $19.8 million in 2022, then fell by 26.25% to $14.6 million in 2023, then surged by 70.15% to $24.9 million in 2024, then fell by 1.27% to $19.5 million in 2025.
- Its Non-Current Debt was $19.5 million in Q3 2025, compared to $21.4 million in Q2 2025 and $23.1 million in Q1 2025.